Navigation Links
NYU Cancer Institute researcher among first NIH EUREKA award recipients
Date:9/3/2008

New York City, NY September 3, 2008 - The National Institutes of Health (NIH) has awarded $42.2 million to fund 38 exceptionally innovative research projects that could have an extraordinarily significant impact on many areas of science. The grants, from a new program called EUREKA (for Exceptional, Unconventional Research Enabling Knowledge Acceleration), targets investigators who are testing novel, unconventional hypotheses or are pursuing major methodological or technical advances. Eureka researchers will receive direct costs of approximately $200,000 per year for up to four years.

Michelle Krogsgaard, Ph.D, assistant professor of pathology at the NYU Cancer Institute, is the first NYU School of Medicine recipient of the EUREKA award. In 2006, Dr. Krogsgaard joined NYU and her work has focused on the different signaling methods T-cells use in the contexts of cancer and autoimmune disease. The EUREKA award will allow Dr. Krogsgaard to explore the complex molecular mechanisms that govern the training and activation of immune cells; specifically, how intracellular signals are generated in T-cells, currently an immunological black box. Dr. Krogsgaard practices an interdisciplinary approach to her research, which incorporates cellular, chemical and structural biology techniques. Through this fresh perspective and multidisciplinary approach, Dr. Krogsgaard aims to build on her previous training to initiate a novel and risky approach to study mechanisms of T-cell signaling and to bolster her controversial hypothesis that structural changes in the receptor complex are important for T-cell signaling. This award will give her the freedom to explore innovative techniques and interdisciplinary approaches that would not be supported by an R01 award.

Using a combination of novel imaging and biophysical techniques, Dr. Krogsgaard investigates how one can manipulate signaling mechanisms in T-cells which could enhance the immune response in patients w
'/>"/>

Contact: Jennifer Berman
Jennifer.Berman@nyumc.org
212-404-3555
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Blood fingerprints for cancer
2. Height linked to risk of prostate cancer development and progression
3. TGen and Washington University researchers discover new approach to treating endometrial cancer
4. Landmark study opens door to new cancer, aging treatments
5. Growth factor predicts poor outcome in breast cancer
6. Researchers discover atomic bomb effect results in adult-onset thyroid cancer
7. AACR hosts Molecular Diagnostics in Cancer Therapeutic Development Meeting
8. Normalizing tumor vessels to improve cancer therapy
9. CSHL scientists identify new drug target against virulent type of breast cancer
10. Gene therapy anti-cancer research featured in Scientific American
11. Dense tissue promotes aggressive cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2015)... , June 16, 2015 Fingerprint ... previously communicated that it will amount to at least 340 ... Due to the rapid increase in market growth and orders ... previously communicated guidance that revenue for 2015 will exceed 1,500 ... amount to approximately 2,200 MSEK. Due to receipt ...
(Date:6/15/2015)... , June 15, 2015 A ... from Telstra reveals the majority of US consumers using mobile ... via biometrics, such as fingerprint and voiceprint, instead of having ... According to Telstra,s " Mobile Identity   -   ... report, with smartphones now the primary channel used by ...
(Date:6/12/2015)... June 12, 2015  Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring, announced ... to electronically capture, analyze and identify participants of ... methods. This system can: ... enrollment and subsequent sign-on process is actually the ...
Breaking Biology News(10 mins):Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2
... and other businesses step up efforts to cut waste, ... their products and processes, the number of planet-friendly standards ... creating a sometimes-confusing array of options for "going green." ... prototyped a framework to help organizations of all types ...
... American Naturalist :, , Cuttlefish: From camo to tuxedo in ... can twins tell us about mate choice? For the ... For more information or for photos (where available), contact ... to tuxedo in less than a second Cuttlefish have ...
... NORTHRIDGE, CA (April 26, 2011) Folic acid, an essential ... liquid softgel capsule, is absorbed and available within the body ... according to a study presented in a late breaking session ... formulations, fillers and coatings of vitamin products may affect the ...
Cached Biology News:NIST prototypes framework for evaluating sustainability standards 2Tipsheet for the May issue of the American Naturalist 2Tipsheet for the May issue of the American Naturalist 3Study examines folic acid absorption rates from softgel capsule and standard tablet 2
(Date:7/1/2015)... , ... July 01, 2015 , ... Apex Therapeutics announced ... International Convention in Philadelphia, PA. , The presentation took place on Tuesday, ... the plans for the development of APX3330 for the treatment of pancreatic cancer. ...
(Date:6/30/2015)... 2015 R-Japan Co.,Ltd. obtained the license of cell ... Medicine from the Ministry of Health, Labour and Welfare Kinki ... The fact that R- Japan ... from Pharmaceuticals and Medical Devices Agency (PMDA) on May 18, ... provide stem cell manufacturing service to medical institutions. As of ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... a webinar to provide advanced scientific research into new classes of Nanoscale Graphene-based ... energy. Touted as 'the wonder material of the 21st Century' by the ...
(Date:6/30/2015)... Americord Registry, one of the fastest growing cord blood banks ... at Kirkland & Ellis LLP, as the newest member of ...   "We are thrilled about Andrew Horne,s ... , CEO of Americord. "He brings a wealth of knowledge ... growth and vision." Andrew Horne is ...
Breaking Biology Technology:Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 3How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 4Americord Registry Announces Andrew Horne as Advisory Board Member 2
... (OTC Bulletin Board: CSBR ), a company ... tumor specific data to enhance the value of oncology ... the management team as the Chief Executive Officer of ... Ronnie Morris will join the management team as President ...
... Oct. 28 Q3 2010 Change on a reported ... 9 months 2010Change on a reported ... sales , €7,821m+5.7% , -1.7% , €22,989m+4.8% , ... €7,377m+8.7% , +6.0%Business EPS(1)€1.89+8.6%-2.3%€5.65+8.7%+6.0% In order to facilitate an understanding ...
... Taking Control of Diabetes: Support World Diabetes Day (14th November 2010) -- LONDON, October 28, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by ...
Cached Biology Technology:Champions Biotechnology Reports Additions to its Management Team 2Champions Biotechnology Reports Additions to its Management Team 3Champions Biotechnology Reports Additions to its Management Team 4Resilient Sales and Business EPS(1) in Q3 2010 2Resilient Sales and Business EPS(1) in Q3 2010 3Resilient Sales and Business EPS(1) in Q3 2010 4Resilient Sales and Business EPS(1) in Q3 2010 5Resilient Sales and Business EPS(1) in Q3 2010 6Resilient Sales and Business EPS(1) in Q3 2010 7Resilient Sales and Business EPS(1) in Q3 2010 8Resilient Sales and Business EPS(1) in Q3 2010 9Resilient Sales and Business EPS(1) in Q3 2010 10Resilient Sales and Business EPS(1) in Q3 2010 11Resilient Sales and Business EPS(1) in Q3 2010 12Resilient Sales and Business EPS(1) in Q3 2010 13Resilient Sales and Business EPS(1) in Q3 2010 14Resilient Sales and Business EPS(1) in Q3 2010 15Resilient Sales and Business EPS(1) in Q3 2010 16Resilient Sales and Business EPS(1) in Q3 2010 17Resilient Sales and Business EPS(1) in Q3 2010 18Resilient Sales and Business EPS(1) in Q3 2010 19Resilient Sales and Business EPS(1) in Q3 2010 20Resilient Sales and Business EPS(1) in Q3 2010 21Resilient Sales and Business EPS(1) in Q3 2010 22Resilient Sales and Business EPS(1) in Q3 2010 23Resilient Sales and Business EPS(1) in Q3 2010 24Resilient Sales and Business EPS(1) in Q3 2010 25Resilient Sales and Business EPS(1) in Q3 2010 26Resilient Sales and Business EPS(1) in Q3 2010 27Resilient Sales and Business EPS(1) in Q3 2010 28Resilient Sales and Business EPS(1) in Q3 2010 29Resilient Sales and Business EPS(1) in Q3 2010 30Resilient Sales and Business EPS(1) in Q3 2010 31Resilient Sales and Business EPS(1) in Q3 2010 32Resilient Sales and Business EPS(1) in Q3 2010 33
... is the most thoroughly characterized enzyme available ... its overall utility and efficacy. , Its ... PCR applications. , It is QC ... AmpliTaq DNA Polymerase is a 94 kDa ...
Taq DNA Polymerase (T. aquaticus), 4 x 250 units. For PCR and other procedures requiring DNA polymerase activity at elevated temperatures. Category: Nucleotides & Enzymes & Biochemicals, Modifying En...
... DNA Polymerase is a versatile and easy-to ... PCR applications. GCpro Taq DNA Polymerase is ... E. coli, containing the DNA polymerase I ... a highly processive 5'-3' DNA polymerase activity. ...
Aspergillus (IgG) Ab EIA Sample Size: 100 l...
Biology Products: